biote Corp. (BTMD) income statement
BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3069% below fair value
$0.89−0.10 (-10.51%)
Close on Nov 18, 2026Market cap $31.83MP/E 8.9Yield –
biote Corp. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 68.6%
- Operating margin
- 8.0%
- Net margin
- 3.2%
- Return on equity, FY2025
- -32.9%
Financial strength
- Current ratio
- 1.43
- Debt to equity
- -1.85
- Debt to assets
- 119.5%
- Cash to current liabilities
- 37.1%
Valuation
- P/E ratio
- 8.9
- Price to sales
- 0.17
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?